CORRECTION article

Front. Cell. Infect. Microbiol., 18 August 2025

Sec. Molecular Bacterial Pathogenesis

Volume 15 - 2025 | https://doi.org/10.3389/fcimb.2025.1656235

Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine

  • 1. Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

  • 2. Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Bangkok, Thailand

  • 3. Vaccine Formulation Institute, Plan-Les-Ouates, Switzerland

  • 4. Medical Microbiology, Interdisciplinary Program, Graduate School, Chulalongkorn University, Bangkok, Thailand

  • 5. Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand

  • 6. Laboratory Animal Section, Analysis Division, Armed Force Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand

The animal facility was misidentified in the Materials and Methods section.

A correction has been made to the section Materials and Methods, subsection Immunization and Challenge in Hamsters, paragraph 1:

The sentence originally read:

“Outbred golden Syrian hamsters were purchased from the North-East Animal Laboratory Center, Khon Kaen University, Thailand.”

It has been corrected to:

“Outbred golden Syrian hamsters were obtained from the Animal Unit, Faculty of Medicine, Khon Kaen University, Thailand, which served as the animal resource provider for this study.”

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Leptospira, immunoglobulin-like protein A, subunit vaccine, adjuvant formulation, neutral liposome, squalene-in-water emulsion, QS21 saponin, QuilA saponin

Citation

Techawiwattanaboon T, Courant T, Brunner L, Sathean-anan-kun S, Krangvichian P, Iadsee N, Nakornpakdee Y, Sangjun N, Komanee P, Collin N, Ruxrungtham K and Patarakul K (2025) Correction: Designing adjuvant formulations to promote immunogenicity and protective efficacy of Leptospira immunoglobulin-like protein a subunit vaccine. Front. Cell. Infect. Microbiol. 15:1656235. doi: 10.3389/fcimb.2025.1656235

Received

29 June 2025

Accepted

29 July 2025

Published

18 August 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2025

Updates

Copyright

*Correspondence: Kanitha Patarakul, ;

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics